Sterigenics invests US$16.8m in new US capacity

Investment triples sterilisation capacity at the company's West Memphis facility

The expansion will provide enough capacity to process
around 50,000 additional pallets of product annually

Sterigenics International, a global provider of contract sterilisation, lab services, gamma technologies and medical isotopes, has completed a $16.8 million expansion to its West Memphis, Arkansas, facility, nearly tripling the facility’s gamma sterilisation capacity.

Originally opened in 1999, the current expansion adds a state-of-the art Nordion JS10000 irradiator and boosts the total licensed throughput at West Memphis nearly three-fold, enough capacity to process approximately 50,000 additional pallets of product annually.

Philip Macnabb, President of Sterigenics, said: “We are seeing significant demand for more Gamma capacity in the Southwest, which is why we decided to make this investment in West Memphis. This expansion is a first in a series of investments in capacity that we will be making. It is a very exciting time for our company.”

“Memphis is a key regional logistics hub with a growing demand for sterilisation services,” said Susan Hope, General Manager of the West Memphis facility. “Our customers have been anxiously waiting for this expansion to come on line and we are looking forward to working with them to take advantage of the faster turnaround we now offer.”

At full capacity, the expanded West Memphis facility will add approximately 20 new employees and will allow Sterigenics to better serve customers throughout the region.

Sterigenics International operates out of 43 facilities in 13 countries across the Americas, Europe and Asia, providing contract sterilisation and ionisation services for the medical device, pharmaceutical, food safety, and high-performance materials industries.

Companies